Tumors evading CARs—the chase is on Journal Article

  


Authors: Rafiq, S.; Brentjens, R. J.
Article Title: Tumors evading CARs—the chase is on
Abstract: Acquired resistance to CD19-targeted CAR T cell therapy can occur through mutations in the CD19 gene or after insertion of a chimeric antigen receptor (CAR) into leukemia cells, resulting in the adjacent receptor being masked by the CAR. © 2018, Springer Nature America, Inc.
Journal Title: Nature Medicine
Volume: 24
Issue: 10
ISSN: 1078-8956
Publisher: Nature Publishing Group  
Date Published: 2018-10-01
Start Page: 1492
End Page: 1493
Language: English
DOI: 10.1038/s41591-018-0212-6
PUBMED: 30297897
PROVIDER: scopus
DOI/URL:

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85054665750&doi=10.1038%2fs41591-018-0212-6&partnerID=40&md5=486c942dda187d34137e1c0cfa696156
Notes: Note -- Export Date: 1 November 2018 -- Source: Scopus
Altmetric
What is Altmetric?
Citation Impact
What is Dimensions Citation Badge?
BMJ Impact Analytics
MSK Authors
  1. Renier J Brentjens
    286 Brentjens
  2. Sarwish Rafiq
    15 Rafiq
Related MSK Work